Tech Company Financing Transactions
Salvia BioElectronics Funding Round
Innovation Industries, Brabant Development Agency and Dolby Family Ventures participated in a $60 million Series B funding round for Salvia BioElectronics. The round was announced on 5/27/2025.
Transaction Overview
Company Name
Announced On
5/27/2025
Transaction Type
Venture Equity
Amount
$60,000,000
Round
Series B
Investors
Proceeds Purpose
The fresh capital will support completion of the company's pivotal clinical study, RECLAIM, as well as regulatory filings and commercial launch preparations in the United States, Europe, and Australia.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
High Tech Campus 37
Eindhoven, 5656 AE
The Netherlands
Eindhoven, 5656 AE
The Netherlands
Phone
Undisclosed
Website
Email Address
Overview
People with migraine deserve more than relief, they deserve to reclaim their life; Salvia BioElectronics is pioneering neuromodulation therapy aiming to transform the migraine treatment landscape. Designed to provide meaningful relief, MySalvia Therapy features an ultra-thin implant that comprehensively targets key nerves involved in migraine.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 5/27/2025: Alba Health venture capital transaction
Next: 5/27/2025: EnduroSat venture capital transaction
Share this article
Where The Data Comes From
We record all VC transactions involving tech companies. VC investment data records reported here are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs